SCP
EBS icon

Seizert Capital Partners’s Emergent Biosolutions EBS Stock Holding History

Seizert Capital Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102,375
Closed -$3.18M – 187
2022
Q2 		$3.18M Buy
102,375
+38,859
+61% +$1.33M 0.17% 95
2022
Q1 		$2.61M Buy
63,516
+51
+0.1% +$2.25K 0.12% 108
2021
Q4 		$2.76M Buy
63,465
+1,611
+3% +$72.9K 0.12% 108
2021
Q3 		$3.1M Buy
61,854
+36,047
+140% +$2.18M 0.14% 104
2021
Q2 		$1.63M Buy
+25,807
New +$1.66M 0.08% 119
2017
Q1 		– Sell
-102,413
Closed -$3.36M – 221
2016
Q4 		$3.36M Buy
102,413
+411
+0.4% +$12.3K 0.12% 99
2016
Q3 		$3.22M Sell
102,002
-7,512
-7% -$218K 0.12% 97
2016
Q2 		$3.08M Buy
109,514
+6,580
+6% +$258K 0.12% 98
2016
Q1 		$3.74M Buy
102,934
+29,222
+40% +$1.03M 0.13% 97
2015
Q4 		$2.95M Sell
73,712
-21,808
-23% -$760K 0.09% 122
2015
Q3 		$2.72M Sell
95,520
-13,003
-12% -$428K 0.08% 125
2015
Q2 		$3.58M Sell
108,523
-54,203
-33% -$1.68M 0.09% 120
2015
Q1 		$4.68M Sell
162,726
-75,590
-32% -$2.17M 0.12% 107
2014
Q4 		$6.49M Sell
238,316
-12,819
-5% -$306K 0.14% 87
2014
Q3 		$5.35M Buy
251,135
+89,965
+56% +$2.06M 0.11% 99
2014
Q2 		$3.62M Buy
161,170
+106,126
+193% +$2.47M 0.07% 121
2014
Q1 		$1.39M Buy
55,044
+4,547
+9% +$115K 0.03% 120
2013
Q4 		$1.16M Sell
50,497
-28,015
-36% -$584K 0.03% 128
2013
Q3 		$1.5M Buy
78,512
+6,170
+9% +$110K 0.04% 90
2013
Q2 		$1.04M Buy
+72,342
New +$1.05M 0.03% 107

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Seizert Capital Partners's EBS Position: Q3 2022 in Review

Seizert Capital Partners sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 102,375 shares — an estimated $3.18M sold.

Seizert Capital Partners first reported a position in EBS in Q2 2013 and held it in 20 quarters. The position peaked at $6.49M in Q4 2014. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Seizert Capital Partners reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 102,375 Emergent Biosolutions shares in Q3 2022, an estimated $3.18M.
  • Seizert Capital Partners first reported a position in Emergent Biosolutions in Q2 2013 and held it in 20 quarters.
  • Seizert Capital Partners's Emergent Biosolutions position peaked at $6.49M in Q4 2014.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Seizert Capital Partners's 13F filing for Q3 2022, filed 2 Nov 2022.